ALKALI vs EPIGRAL: Stock Comparison
EPIGRAL is the larger company by market capitalisation. ALKALI shows a higher dividend yield, while EPIGRAL shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ALKALI leads 4; EPIGRAL leads 7 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ALKALI | EPIGRAL |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | ALKALI | EPIGRAL |
|---|---|---|
| Live Price | ₹96.37 | ₹902.4 |
| Day Change | -5.18% | -0.54% |
| Volume | 55,361 | 3,550 |
| 52-Week High | ₹106.3 | ₹1,716.4 |
| 52-Week Low | ₹46.8 | ₹807 |
| Distance from 52W High | -9.34% | -47.42% |
Valuation
| Metric | ALKALI | EPIGRAL |
|---|---|---|
| Market Cap | ₹76 Cr | ₹3,926 Cr |
| P/E Ratio | — | 14.49x |
| P/B Ratio | — | 1.77x |
| EPS | ₹0.57 | ₹62.69 |
| Book Value | ₹43.89 | ₹514.92 |
| Dividend Yield | 1.35% | 0.55% |
Growth
| Metric | ALKALI | EPIGRAL |
|---|---|---|
| Revenue Growth (TTM YoY) | 2.98% | 17.3% |
| EPS Growth (TTM YoY) | 0% | -6.8% |
| Qtr Sales Growth | 55.23% | 0% |
| Qtr Profit Growth | 189.37% | 0% |
Profitability & Leverage
| Metric | ALKALI | EPIGRAL |
|---|---|---|
| ROE | 1.25% | 14.99% |
| ROCE | 1.46% | 11.04% |
| Net Margin | 0.6% | 13.14% |
| Operating Margin | 5.86% | 16.37% |
| Debt to Equity | 0.4x | 0.25x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | ALKALI | EPIGRAL |
|---|---|---|
| Promoter Holding | 68.51% | 68.83% |
| FII Holding | 0% | 0.99%▼ 0.04 pp |
| DII Holding | 0% | 4.9%▼ 0.66 pp |
| Public Holding | 30.41% | 25.26%▲ 0.71 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALKALI and EPIGRAL.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.